We are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically-relevant proteins. We have developed a proprietary protein degradation platform, called QuEEN, that enables us to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates that are designed to […]

We are a genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines. Despite advances in treatment over the last 50 years, CVD remains the leading cause of death worldwide. The current paradigm of chronic care is fragile—requiring rigorous patient […]

(Note: Soulgate Inc. withdrew its IPO prospectus in an SEC filing dated June 9, 2022. Last year: Soulgate postponed its IPO on Wednesday morning, June 23, 2021 – hours ahead of its scheduled pricing that night. Soulgate filed its F-1 on May 10, 2021.) (Note: This is an IPO of 13.2 million American Depositary Shares (ADS), […]

Our mission: Eliminate the organ transplant waiting list. We are a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. Organ disease is a major public health issue. According to the American Transplant Foundation there are an estimated 114,000 people in the United States […]

Note: This is the sixth SPAC or blank-check company created under the JAWS name and led by Barry Sternlicht, the founder, chairman and CEO of Starwood Capital. (Incorporated in the Cayman Islands) We intend to focus our efforts on wireless communications and related technology/product/service businesses that have attractive growth-oriented characteristics and strong underlying demand drivers. We […]

Note: This is the second blank-check company — in a group of three under the Corner Growth Acquisition name – established by John Cadeddu and Marvin Tien, the co-founders and general partners of Corner Ventures, a venture capital firm focused on investing in fast-growing technology companies. (Incorporated in the Cayman Islands) Our focus will be […]

Confluent is on a mission to set data in motion. We have pioneered a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. This new data infrastructure software has emerged as one of the most strategic parts of the next-generation […]

Note: LinkDoc Technology Limited withdrew its IPO prospectus in an SEC filing dated April 11, 2022. LinkDoc filed its S-1 (prospectus) on June 14, 2021.  At LinkDoc, our mission is to make precision medicine and personalized care a reality by uncovering the story of every patient journey through the power of data and artificial intelligence. […]

(Note: This is NOT a traditional IPO. This is a NASDAQ uplisting from the AIM in London, where the ordinary shares of Tremor International closed on June 11, 2021, at US$22.17 per share. This uplisting is an offering of 6.77 American Depositary Shares (ADS) to trade on the NASDAQ. Each ADS represents two ordinary shares.) […]

We intend to capitalize on the Zimmer platform to identify, acquire and operate a business in industries that may provide opportunities for attractive risk-adjusted returns in the energy value chain in North America, with a focus on energy transition and sustainability. This includes environmental, social and governance growth-focused companies in the energy, industrial and infrastructure […]